Beta-Lactam Antibiotics: Recommended Agents and Dosing for Common Adult Infections
For most common adult infections, beta-lactam selection and dosing should be guided by infection site, severity, and risk factors for resistant organisms, with higher doses and prolonged/continuous infusions strongly recommended for critically ill patients.
Community-Acquired Pneumonia (CAP)
Non-ICU Hospitalized Patients
The preferred beta-lactam regimens include 1, 2:
- Ceftriaxone 1-2 g IV every 12-24 hours (most commonly used)
- Cefotaxime 1-2 g IV every 6-8 hours
- Ampicillin 1 g IV every 6 hours
- Ertapenem 1 g IV every 24 hours (for patients with risk factors for gram-negative pathogens excluding Pseudomonas)
All beta-lactams should be combined with a macrolide (azithromycin or clarithromycin) or used as monotherapy only with a respiratory fluoroquinolone 1, 2.
ICU Patients
For severe CAP requiring ICU admission 1:
- Ceftriaxone 1-2 g IV every 12-24 hours OR cefotaxime 1-2 g IV every 6-8 hours OR ampicillin-sulbactam
- PLUS azithromycin (level II evidence) or a fluoroquinolone (level I evidence)
Pseudomonas Risk
When Pseudomonas aeruginosa is suspected 1:
- Piperacillin-tazobactam 3.375-4.5 g IV every 6 hours (or 4.5 g every 4 hours for Pseudomonas)
- Cefepime 2 g IV every 8-12 hours
- Meropenem 1 g IV every 8 hours
- PLUS ciprofloxacin or levofloxacin 750 mg, OR aminoglycoside plus azithromycin
Duration: Generally 5-8 days for responding patients; biomarkers like procalcitonin may guide shorter courses 2.
Intra-Abdominal Infections
Mild to Moderate Community-Acquired
The WHO 2024 guidelines 3 recommend:
- First choice: Amoxicillin-clavulanate (dosing not specified in guidelines, but standard is 1.2-2.2 g IV every 6-8 hours)
- Second choice: Cefotaxime or ceftriaxone PLUS metronidazole
- Alternative: Ampicillin PLUS gentamicin PLUS metronidazole
Severe Intra-Abdominal Infections
For high-risk or severely ill patients 4, 3:
- Piperacillin-tazobactam 3.375 g IV every 6 hours (increase to 4.5 g every 6 hours for Pseudomonas)
- Meropenem 1 g IV every 8 hours
- Cefotaxime or ceftriaxone PLUS metronidazole (with ampicillin added for enterococcal coverage if needed)
Alternative regimens include 4:
- Imipenem-cilastatin 500 mg every 6 hours or 1 g every 8 hours
- Doripenem 500 mg every 8 hours
- Ertapenem 1 g every 24 hours (no Pseudomonas coverage)
Duration: 4-7 days for adequate source control 4. Longer courses have not shown additional benefit.
Sepsis and Septic Shock
Critical Dosing Principles
For critically ill septic patients, standard dosing is frequently inadequate 5, 6:
Loading doses are essential to rapidly achieve therapeutic levels due to expanded extracellular volume from resuscitation 5:
- Piperacillin-tazobactam: Give one standard dose (3.375-4.5 g) over 30 minutes, then continue standard dosing
- Cefepime: 2 g loading dose
- Meropenem: 1-2 g loading dose
Prolonged or continuous infusion after loading dose significantly improves outcomes 5, 6, 7:
- Continuous infusion is preferred for beta-lactams in severe sepsis
- Piperacillin-tazobactam: 3.375 g every 4 hours OR 16 g/day continuous infusion (after loading)
- Meropenem: 1 g every 8 hours as 3-hour infusion OR continuous infusion
- Cefepime: 2 g every 8 hours as extended infusion
The 2026 consensus 7 demonstrated 98.76% posterior probability that prolonged infusion reduces mortality and 99.97% probability it improves clinical cure in severely ill adults.
Augmented Renal Clearance
In patients with preserved or augmented renal function 6:
- Higher daily doses are required: up to 12 g ceftazidime or 24 g piperacillin daily
- Standard dosing achieves target concentrations in only 16-44% of ICU patients 6
Key Pharmacokinetic Targets
Beta-lactams are time-dependent antibiotics requiring 5, 6:
- Minimum target: Free drug concentration above MIC for 60% of dosing interval (60% fT>MIC)
- Optimal target for severe infections: 100% fT>MIC
- Upper safety limit: Avoid free trough concentrations >8× MIC to prevent neurotoxicity 6
Specific neurotoxicity thresholds 6:
- Cefepime: Trough <22 mg/L (intermittent) or steady-state <35 mg/L (continuous)
- Meropenem: Trough <64 mg/L
- Piperacillin: Steady-state <157 mg/L (with tazobactam)
Penicillin Allergy Considerations
For patients with severe beta-lactam allergies 1, 4:
- Respiratory fluoroquinolone (levofloxacin 750 mg or moxifloxacin 400 mg) PLUS aztreonam
- Aztreonam 1-2 g IV every 6-8 hours (safe in penicillin allergy)
- Aminoglycoside-based regimens with metronidazole for intra-abdominal infections
Common Pitfalls to Avoid
Underdosing in early sepsis: Standard doses fail to achieve targets in 55-72% of ICU patients 6. Always use loading doses and consider higher maintenance doses.
Ignoring augmented renal clearance: Young patients without chronic kidney disease often have enhanced drug elimination requiring dose escalation 6.
Short infusions in severe illness: Intermittent 30-minute infusions are inferior to extended/continuous infusions for mortality and cure rates 7.
Inadequate Pseudomonas coverage: When risk factors exist (structural lung disease, prior colonization, healthcare exposure), antipseudomonal beta-lactams are mandatory 1.
Excessive duration: For intra-abdominal infections with adequate source control, extending beyond 7 days provides no benefit 4.
Missing enterococcal coverage: When using ceftriaxone-metronidazole for severe intra-abdominal infections, add ampicillin for enterococcal coverage 3.